Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 10/12/05  and contains information from public web pages.

Dr. Luca Dalla Paola

Wrong Dr. Luca Dalla Paola?
 
Background

Employment History

  • Surgeon With the Diabetic Foot Unit
    Abano Terme Hospital
9 Total References
Web References
Post-Approval
genetown.biospace.com, 12 Oct 2005 [cached]
Oculus Innovative Sciences ...
www.fdanews.com [cached]
Oculus Innovative Sciences announced that Luca Dalla Paola, a surgeon with the diabetic foot unit of the Abano Terme Hospital in Italy, recently presented the results of a 218-patient controlled clinical study that assessed the safety and efficacy of Microcyn Technology in treating diabetic foot ulcers as compared to povidone iodine (10%) antiseptic, which is often used as the "standard care" in treatment of open wounds.
Infection Control Today - Results of a Clinical Study Evaluating Treatment of Diabetic Foot Ulcers Using Microcyn Technology Presented at Wound Management Conference
www.infectioncontroltoday.com, 5 Oct 2005 [cached]
STUTTGART, Germany -- Oculus Innovative Sciences, Inc. announces that Dr. Luca Dalla Paola, a surgeon with the diabetic foot unit of the Abano Terme Hospital in Italy, recently presented the results of a 218-patient controlled clinical study that assessed the safety and efficacy of Microcyn technology in treating diabetic foot ulcers as compared to povidone iodine (10 percent) antiseptic, which is often used as the "standard care" in treatment of open wounds.
STUTTGART, GERMANY-- (October 4, 2005)- ...
www.oculusis.com, 4 Oct 2005 [cached]
STUTTGART, GERMANY-- (October 4, 2005)- Oculus Innovative Sciences, Inc. announced that Dr. Luca Dalla Paola, a surgeon with the diabetic foot unit of the Abano Terme Hospital in Italy, recently presented the results of a 218-patient controlled clinical study that assessed the safety and efficacy of Microcyn® Technology in treating diabetic foot ulcers as compared to povidone iodine (10%) antiseptic, which is often used as the "standard care" in treatment of open wounds.
RESULTS OF CLINICAL STUDY EVALUATING TREATMENT OF DIABETIC FOOT ULCERS USING MICROCYN™ TECHNOLOGY PRESENTED AT STUTTGART2005
www.oculusis.com, 4 Oct 2005 [cached]
STUTTGART, GERMANY-- (October 4, 2005)- Oculus Innovative Sciences, Inc. announced that Dr. Luca Dalla Paola, a surgeon with the diabetic foot unit of the Abano Terme Hospital in Italy, recently presented the results of a 218-patient controlled clinical study that assessed the safety and efficacy of Microcyn® Technology in treating diabetic foot ulcers as compared to povidone iodine (10%) antiseptic, which is often used as the "standard care" in treatment of open wounds.
Other People with the name "Paola":
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304